Sodium Molybdate Liquid
NDC Package 63518-4200-0
Package Information
Sodium Molybdate liquids is a drug for further processing. This formulation utilizes a liquid delivery system. Marketed by Curium Netherlands B.v., this product is identified by NDC 63518-4200.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63518 - Curium Netherlands B.v.
- 63518-4200 -
- 63518-4200-0 - 125 mL in 1 VIAL
- 63518-4200 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63518-4200-0 identifies a specific commercial package of 125 ml in 1 vial of Sodium Molybdate (UNFINISHED drug), drug for further processing labeled by Curium Netherlands B.v.. This liquid is formulated for use and contains sodium molybdate mo-99 as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Curium Netherlands B.v. on November 11, 2015. The current certification is valid through December 31, 2026.
How is this Curium Netherlands B.v. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63518420000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.